Author Question: James is a clinical researcher who is interested in methods for reducing the intrusiveness of ... (Read 93 times)

Davideckstein7

  • Hero Member
  • *****
  • Posts: 555
James is a clinical researcher who is interested in methods for reducing the intrusiveness of auditory hallucinations in individuals with paranoid schizophrenia. He has three treatments: dialectical behavioral therapy (DBT), medication, and deep brain stimulation (DBS). He also has three treatment settings: inpatient, day hospital, and outpatient. Although the participants in all three settings can receive DBT and medication, only those who are inpatient can receive DBS. As a result, James has a total of seven groups: DBT-Inpatient, DBT-Day Hospital, DBT-Outpatient, Medication-Inpatient, Medication-Day Hospital, Medication-Outpatient, and DBS-Inpatient. This design is best classified as a(n) ____ factorial.
 
  a. imperfect
 b. incomplete
  c. partial
 d. limited

Question 2

The use of nonsense syllables was not a perfect solution to the problems Ebbinghaus hoped to avoid by their use because
 
  a. nonsense syllables are hard to learn.
  b. he was the only subject in his experiments.
  c. meaning may be attached to nonsense syllables.
  d. none of these



pallen55

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

b

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

More than 20 million Americans cite use of marijuana within the past 30 days, according to the National Survey on Drug Use and Health (NSDUH). More than 8 million admit to using it almost every day.

Did you know?

Eating carrots will improve your eyesight. Carrots are high in vitamin A (retinol), which is essential for good vision. It can also be found in milk, cheese, egg yolks, and liver.

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library